Lucid Diagnostics Inc. (LUCD) vs Pulmonx Corporation (LUNG)
- Lucid Diagnostics Inc. LUCD 0.48 −7.69%
- Pulmonx Corporation LUNG 1.78 −3.78%
Lucid Diagnostics Inc. and Pulmonx Corporation are both Medical Devices companies. Lucid Diagnostics Inc. is the larger, with a market value of $105.7M against $79.5M — 1.3× the size. Lucid Diagnostics Inc. grew revenue faster over the last twelve months: 24.9% against −3.43%. Pulmonx Corporation has the higher net margin (−55.0% vs −1,193.9%) and the higher return on invested capital (−141.0% vs −3,096.5%). Across the 17 metrics below, Pulmonx Corporation leads on 13 and Lucid Diagnostics Inc. on 4.
Valuation
Profitability
| Metric | LUCD | LUNG | Medical Devices median |
|---|---|---|---|
| Gross margin | (21.69%) | 77.06% | 56.01% |
| Operating margin | (930.84%) | (52.96%) | (15.03%) |
| Net margin | (1,193.87%) | (55.03%) | (20.40%) |
| Free cash flow margin | (866.56%) | (35.07%) | (7.24%) |
| Return on equity | 364.89% | (88.87%) | (15.32%) |
| Return on assets | (167.51%) | (36.74%) | (19.72%) |
| Return on invested capital | (3,096.53%) | (141.03%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack